$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000121390023076079 Filed on September 12, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$54.00K	$110.0K	$287.0K
YoY Change	-37.93%		22.65%
Cost Of Revenue		$10.00K	$9.000K
YoY Change
Gross Profit	$54.00K	$100.0K	$278.0K
YoY Change			18.8%
Gross Profit Margin	100.0%	90.91%	96.86%
Selling, General & Admin	$2.440M	$3.120M	$11.78M
YoY Change	-10.95%	-11.39%	-32.49%
% of Gross Profit	4518.52%	3120.0%	4237.41%
Research & Development	$3.366M	$4.000M	$17.41M
YoY Change	-25.25%	-25.93%	-29.23%
% of Gross Profit	6233.33%	4000.0%	6263.67%
Depreciation & Amortization	$67.00K	$70.00K	$362.0K
YoY Change	-33.0%	-49.28%	-65.62%
% of Gross Profit	124.07%	70.0%	130.22%
Operating Expenses	$3.366M	$6.650M	$17.41M
YoY Change	-25.25%	-25.13%	-29.23%
Operating Profit	-$5.377M	-$6.550M	-$27.25M
YoY Change	-22.33%		-34.49%
Interest Expense	$214.0K	-$60.00K	$843.0K
YoY Change	-210.31%	-70.3%	-4.96%
% of Operating Profit
Other Income/Expense, Net	$279.0K		-$1.641M
YoY Change	-67.1%		-849.32%
Pretax Income	-$5.100M	-$6.610M	-$28.89M
YoY Change	-18.65%	-27.23%	-30.17%
Income Tax
% Of Pretax Income
Net Earnings	-$4.961M	-$6.610M	-$28.32M
YoY Change	-18.95%	-27.23%	-31.33%
Net Earnings / Revenue	-9187.04%	-6009.09%	-9867.94%
Basic Earnings Per Share	-$0.12		-$0.78
Diluted Earnings Per Share	-$0.12	-$0.16	-$0.78
COMMON SHARES
Basic Shares Outstanding	41.35M shares	41.12M shares	36.65M shares
Diluted Shares Outstanding	41.33M shares		36.65M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.61M	$40.17M	$40.17M
YoY Change	-30.0%	-26.98%	-26.99%
Cash & Equivalents	$5.253M	$5.360M	$5.360M
Short-Term Investments	$28.36M	$34.81M	$34.81M
Other Short-Term Assets	$1.650M	$1.130M	$710.0K
YoY Change	-3.4%	-58.62%	-49.65%
Inventory
Prepaid Expenses		$442.0K
Receivables			$250.0K
Other Receivables			$280.0K
Total Short-Term Assets	$35.26M	$41.41M	$41.41M
YoY Change	-29.09%	-28.29%	-28.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$768.0K	$688.0K	$8.320M
YoY Change	8.63%	-6.9%	-7.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.000K	$1.000K	$1.070M
YoY Change	40.0%	-92.86%	-18.32%
Total Long-Term Assets	$9.284M	$9.388M	$9.390M
YoY Change	-7.45%	-9.01%	-9.01%
TOTAL ASSETS
Total Short-Term Assets	$35.26M	$41.41M	$41.41M
Total Long-Term Assets	$9.284M	$9.388M	$9.390M
Total Assets	$44.54M	$50.80M	$50.80M
YoY Change	-25.46%	-25.37%	-25.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$970.0K	$1.810M	$1.810M
YoY Change	-27.01%	1.4%	1.12%
Accrued Expenses	$1.024M	$1.209M	$3.670M
YoY Change	2.91%	-25.83%	-18.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.322M	$5.621M	$5.620M
YoY Change	-13.87%	-17.69%	-17.72%
LONG-TERM LIABILITIES
Long-Term Debt	$23.17M	$23.53M	$23.53M
YoY Change	11.81%	8.54%	8.53%
Other Long-Term Liabilities	$6.010M	$6.350M	$6.350M
YoY Change	-15.51%	-13.86%	-13.84%
Total Long-Term Liabilities	$29.18M	$29.88M	$29.88M
YoY Change	4.84%	2.84%	2.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.322M	$5.621M	$5.620M
Total Long-Term Liabilities	$29.18M	$29.88M	$29.88M
Total Liabilities	$33.50M	$35.50M	$37.44M
YoY Change	1.98%	-1.06%	-1.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$404.5M	-$399.6M
YoY Change	7.2%	7.63%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.901M	$13.36M	$13.36M
YoY Change
Total Liabilities & Shareholders Equity	$44.54M	$50.80M	$50.80M
YoY Change	-25.46%	-25.37%	-25.37%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$4.961M	-$6.610M	-$28.32M
YoY Change	-18.95%	-27.23%	-31.33%
Depreciation, Depletion And Amortization	$67.00K	$70.00K	$362.0K
YoY Change	-33.0%	-49.28%	-65.62%
Cash From Operating Activities	-$5.857M	-$2.900M	-$22.86M
YoY Change	-23.03%	-65.59%	-37.38%
INVESTING ACTIVITIES
Capital Expenditures	$103.0K	$90.00K	$262.0K
YoY Change	41.1%	-145.23%	-6.43%
Acquisitions
YoY Change
Other Investing Activities	$5.910M	$4.420M	$9.960M
YoY Change	-8.6%	-260.38%	-17.41%
Cash From Investing Activities	$5.802M	$4.330M	$9.698M
YoY Change	-9.24%	-246.53%	-17.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$8.024M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-10.00K	$8.024M
YoY Change			6.99%
NET CHANGE
Cash From Operating Activities	-$5.857M	-2.900M	-$22.86M
Cash From Investing Activities	$5.802M	4.330M	$9.698M
Cash From Financing Activities		-10.00K	$8.024M
Net Change In Cash	-$97.00K	1.420M	-$5.157M
YoY Change	-92.98%	-112.48%	-74.75%
FREE CASH FLOW
Cash From Operating Activities	-$5.857M	-$2.900M	-$22.86M
Capital Expenditures	$103.0K	$90.00K	$262.0K
Free Cash Flow	-$5.960M	-$2.990M	-$23.12M
YoY Change	-22.42%	-63.66%	-37.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-31392
CY2023	dei	Entity Registrant Name EntityRegistrantName	PLURI INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0351734
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	MATAM Advanced Technology Park
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Building No. 5
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Haifa
CY2023	dei	Entity Address Country EntityAddressCountry	IL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	3508409
CY2023	dei	Security12b Title Security12bTitle	Common Shares, par value $0.00001
CY2023	dei	Trading Symbol TradingSymbol	PLUR
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	34413220	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41351870	shares
CY2023	dei	Auditor Firm AuditorFirmId	1309
CY2023	dei	Auditor Name AuditorName	Kesselman & Kesselman Certified Public Accountants (lsr.)
CY2023	dei	Auditor Location AuditorLocation	Haifa, Israel
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5360000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9772000	usd
CY2023Q2	plur	Shortterm Bank Deposits ShorttermBankDeposits	34811000	usd
CY2022Q2	plur	Shortterm Bank Deposits ShorttermBankDeposits	45244000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	269000	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	1007000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	969000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1724000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	41409000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	57747000	usd
CY2023Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	627000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	634000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	439000	usd
CY2022Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	661000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	688000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	739000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7633000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8270000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	9388000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	10318000	usd
CY2023Q2	us-gaap	Assets Assets	50797000	usd
CY2022Q2	us-gaap	Assets Assets	68065000	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1812000	usd
CY2022Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1785000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1209000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1630000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	627000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	619000	usd
CY2023Q2	plur	Accrued Vacations Current AccruedVacationsCurrent	873000	usd
CY2022Q2	plur	Accrued Vacations Current AccruedVacationsCurrent	1053000	usd
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1100000	usd
CY2022Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1742000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5621000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6829000	usd
CY2023Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	598000	usd
CY2022Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	867000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5748000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6505000	usd
CY2023Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	23530000	usd
CY2022Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	21678000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29876000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29050000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41245495	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41245495	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32507491	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32507491	shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	412939000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	401302000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399584000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-371263000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13355000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	30039000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	1945000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	2147000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15300000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32186000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50797000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68065000	usd
CY2023	us-gaap	Revenues Revenues	287000	usd
CY2022	us-gaap	Revenues Revenues	234000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	9000	usd
CY2023	us-gaap	Gross Profit GrossProfit	278000	usd
CY2022	us-gaap	Gross Profit GrossProfit	234000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17413000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24605000	usd
CY2023	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1668000	usd
CY2022	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	228000	usd
CY2023	plur	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	15745000	usd
CY2022	plur	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	24377000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11779000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17450000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-27246000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-41593000	usd
CY2023	plur	Financial Income Net FinancialIncomeNet	-798000	usd
CY2022	plur	Financial Income Net FinancialIncomeNet	1106000	usd
CY2023	us-gaap	Interest Expense InterestExpense	843000	usd
CY2022	us-gaap	Interest Expense InterestExpense	887000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1641000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	219000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-28887000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-41374000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-566000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-132000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-28321000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-41242000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.28
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36652018	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32192074	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	57151000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8909000	usd
CY2022	plur	Establishment Of Ever After And Noncontrolling Interest In Ever After EstablishmentOfEverAfterAndNoncontrollingInterestInEverAfter	7500000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-41374000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32186000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32186000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3977000	usd
CY2023	plur	Net Of Issuance Costs NetOfIssuanceCosts	445000	usd
CY2023	plur	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	8024000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-28887000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15300000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-28887000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-41374000	usd
CY2023	us-gaap	Depreciation Depreciation	362000	usd
CY2022	us-gaap	Depreciation Depreciation	1053000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3977000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	8909000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-768000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-93000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-22000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-758000	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1243000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-3932000	usd
CY2023	plur	Decrease In Operating Lease Right Of Use Asset And Liability DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability	112000	usd
CY2022	plur	Decrease In Operating Lease Right Of Use Asset And Liability DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability	1148000	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	336000	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	329000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	831000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3207000	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1852000	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-2172000	usd
CY2023	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-47000	usd
CY2022	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-50000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22857000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-36501000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	262000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	280000	usd
CY2023	plur	Proceeds From Withdrawal Of Shortterm Deposits ProceedsFromWithdrawalOfShorttermDeposits	9960000	usd
CY2022	plur	Proceeds From Withdrawal Of Shortterm Deposits ProceedsFromWithdrawalOfShorttermDeposits	12063000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9698000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11783000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8024000	usd
CY2022	plur	Proceeds Related To Investment In Subsidiary By Noncontrolling Interest ProceedsRelatedToInvestmentInSubsidiaryByNoncontrollingInterest	7500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8024000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7500000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-22000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3207000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5157000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20425000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11413000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31838000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6256000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11413000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	5360000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	9772000	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	269000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	1007000	usd
CY2023Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	627000	usd
CY2022Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	634000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6256000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11413000	usd
CY2023	plur	Purchases Of Property And Equipment On Credit PurchasesOfPropertyAndEquipmentOnCredit	74000	usd
CY2022	plur	Purchases Of Property And Equipment On Credit PurchasesOfPropertyAndEquipmentOnCredit	25000	usd
CY2023	plur	Supplemental Noncash Information Related To Lease Liabilities Arising From Obtaining Rou Assets SupplementalNoncashInformationRelatedToLeaseLiabilitiesArisingFromObtainingROUAssets	60000	usd
CY2022	plur	Supplemental Noncash Information Related To Lease Liabilities Arising From Obtaining Rou Assets SupplementalNoncashInformationRelatedToLeaseLiabilitiesArisingFromObtainingROUAssets	8250000	usd
CY2022Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	187500	shares
CY2022Q1	plur	Additional Investment AdditionalInvestment	7500000	usd
CY2023	plur	Total Consideration Amount TotalConsiderationAmount	7500000	usd
CY2023	plur	Amount Equal To Receive AmountEqualToReceive	6718000	usd
CY2023Q2	us-gaap	Shares Issued SharesIssued	782	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0108	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.85	pure
CY2023	plur	Compensation Expense Recognized During The Period CompensationExpenseRecognizedDuringThePeriod	385000	usd
CY2022Q1	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated	45936	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.8034	pure
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1646000	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Use of estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. Estimates are primarily used for, but not limited to, valuation of share-based compensation, valuation of warrants and determining the valuation and terms of leases. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes, and actual results could differ from those estimates.</p>
CY2023	us-gaap	Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>h.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Revenue Recognition</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">A contract with a customer exists only when: (i) the parties to the contract have approved it and are committed to perform their respective obligations, (ii) the Company can identify each party’s rights regarding the distinct goods or services to be transferred (“performance obligations”), (iii) the Company can determine the transaction price for the goods or services to be transferred, (iv) the contract has commercial substance and (v) it is probable that the Company will collect the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Revenues are recognized when the control of the promised goods or the performance of the obligations are transferred to the customer, in an amount that reflects the consideration to which the Company expects to be entitled, excluding sales taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company determines revenue recognition through the following steps:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identification of the contract with a customer;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identification of the performance obligations in the contract;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">determination of the transaction price;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">allocation of the transaction price to the performance obligations in the contract; and</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">recognition of revenue when, or as, the Company satisfies a performance obligation.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p>
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.99
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	2.87
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	993000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1040000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3640000	usd
CY2023	us-gaap	Derivative Cash Received On Hedge DerivativeCashReceivedOnHedge	2426000	usd
CY2022	us-gaap	Derivative Cash Received On Hedge DerivativeCashReceivedOnHedge	293000	usd
CY2023	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	1668000	usd
CY2022	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	228000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14151578	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5247803	shares
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.50	pure
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>o.</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Concentration of credit risk</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, short-term bank deposits, long-term restricted bank deposits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The majority of the Company’s cash and cash equivalents, restricted cash, short-term bank deposits and long-term restricted deposits are mainly invested in New Israeli Shekel (“NIS”) and U.S. dollar deposits of major banks in Israel and in the United States. Deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk. The Company invests its surplus cash in cash deposits in financial institutions and has established guidelines, approved by the Company’s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.</p>
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8971000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2596000	usd
CY2023Q2	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	6375000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	732000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	835000	usd
CY2020Q2	us-gaap	Loans Payable LoansPayable	50000000	eur
CY2020Q2	plur	Contract Period ContractPeriod	36 months
CY2023	plur	Due Date DueDate	June 1, 2026
CY2023Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.04	pure
CY2023	plur	Financial Income Expenses financialIncomeExpenses	157000	usd
CY2022	plur	Financial Income Expenses financialIncomeExpenses	372000	usd
CY2018Q2	plur	Marketing Grant Amount MarketingGrantAmount	52000	usd
CY2018Q2	plur	Royalties Revenues Percentage RoyaltiesRevenuesPercentage	0.03	pure
CY2018Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	250000	usd
CY2018Q2	plur	Beginning Year BeginningYear	P5Y
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	442000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	403000	usd
CY2023Q2	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	129000	usd
CY2022Q2	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	344000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	110000	usd
CY2023Q2	us-gaap	Other Receivables OtherReceivables	38000	usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables	22000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	969000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1724000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18135000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17824000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17447000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17085000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	688000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	739000	usd
CY2023	us-gaap	Depreciation Depreciation	362000	usd
CY2022	us-gaap	Depreciation Depreciation	1053000	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	plur	Deferred Income From Grants DeferredIncomeFromGrants	144000	usd
CY2022Q2	plur	Deferred Income From Grants DeferredIncomeFromGrants	112000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	508000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	624000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	457000	usd
CY2023Q2	plur	Other Accounts Payable Payroll Institutions OtherAccountsPayablePayrollInstitutions	448000	usd
CY2022Q2	plur	Other Accounts Payable Payroll Institutions OtherAccountsPayablePayrollInstitutions	549000	usd
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1100000	usd
CY2022Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1742000	usd
CY2023	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	292000	ils
CY2023	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	83	usd
CY2023	plur	Lease Payments Increase Percentage LeasePaymentsIncreasePercentage	0.10	pure
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7633000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8270000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	627000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	619000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5748000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6505000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6375000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	7124000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1165000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1117000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1016000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1304000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1196000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	36000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	9000	usd
CY2023	plur	Cash Paid For Amounts Included In The Measurement Of Lease Liabilities CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities	1196000	usd
CY2022	plur	Cash Paid For Amounts Included In The Measurement Of Lease Liabilities CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities	1305000	usd
CY2022	plur	Deferred Participation Payment DeferredParticipationPayment	124	usd
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M6D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P9Y1M6D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2020Q2	plur	Subsidiary Loan SubsidiaryLoan	50000000	eur
CY2020Q2	plur	Contract Period ContractPeriod	36 months
CY2023	plur	Contractual Interest Rate For Funds Borrowed ContractualInterestRateForFundsBorrowed	0.04	pure
CY2023	plur	Deferred Interest Rate Percentage DeferredInterestRatePercentage	0.04	pure
CY2021Q2	plur	First Tranche Price FirstTranchePrice	20000000	eur
CY2021Q2	plur	Annual Interest Percentage AnnualInterestPercentage	0.04	pure
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	21722000	usd
CY2023Q2	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	1808000	usd
CY2023Q2	plur	Cash And Deposits CashAndDeposits	896000	usd
CY2023	plur	Percentage Of Qualified Expenditures PercentageOfQualifiedExpenditures	0.50	pure
CY2023	plur	Royalty Rate Sales RoyaltyRateSales	0.03	pure
CY2023	plur	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1	pure
CY2023Q2	plur	Contingent Liability In Respect To Royalties ContingentLiabilityInRespectToRoyalties	27565000	usd
CY2017Q2	plur	Marketing And Business Development Activities MarketingAndBusinessDevelopmentActivities	229000	usd
CY2017Q2	plur	Royalties Revenues Percentage RoyaltiesRevenuesPercentage	0.05	pure
CY2017Q2	plur	Spread Period SpreadPeriod	P5Y
CY2023Q2	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	180000	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	plur	Aggregate Common Shares AggregateCommonShares	8155900	shares
CY2022Q4	us-gaap	Share Price SharePrice	1.03
CY2022Q4	plur	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	5579883	shares
CY2022Q4	plur	Purchase Of Common Shares PurchaseOfCommonShares	5579833	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.03
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.06
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.09
CY2022Q4	plur	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	135000	shares
CY2022Q4	plur	Purchase Of Common Shares PurchaseOfCommonShares	135000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.09
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.12
CY2022Q4	plur	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	135000	shares
CY2022Q4	plur	Purchase Of Common Shares PurchaseOfCommonShares	135000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.12
CY2023Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	8155900	shares
CY2022	plur	Aggregate Gross Proceeds AggregateGrossProceeds	8024000	usd
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	445000	usd
	plur	Common Stock Shares Future Issuance Plan Description CommonStockSharesFutureIssuancePlanDescription	As of June 30, 2023, 6,547,093 common shares are available for future grants under the Plans.
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	usd
CY2022Q4	plur	Annual Cash Salary AnnualCashSalary	375000000	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	334821	shares
CY2023	plur	Ce Os Grant Agreements Description CEOsGrantAgreementsDescription	options to purchase 334,821 common shares, vesting ratably each month, with a term of 3 years, at an exercise price of $1.12 per share.
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.12
CY2023	plur	Average Remaining Maturity Of Stock AverageRemainingMaturityOfStock	P3Y
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	568000	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	174000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1935015	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2404415	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	334821	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	85000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	51389	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	49691	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	560855	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	504709	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1657592	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1935015	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1640570	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1899416	shares
CY2026Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1529000	usd
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1000000	shares
CY2020Q3	plur	Milestone Achievement Value MilestoneAchievementValue	550000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	7.28
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2127000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	273000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1677596	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2023	plur	Schedule Of Financial Income Net ScheduleOfFinancialIncomeNet	FINANCIAL INCOME (EXPENSES), NET<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Foreign currency translation differences, net</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,709</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">922</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Bank and broker commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(16</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest income on deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,084</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">581</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Loss from hedging derivatives</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(157</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(372</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial income (expenses), net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(798</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,106</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">EIB loan interest expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(843</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(887</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,641</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">219</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table>
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1709000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	922000	usd
CY2023	plur	Bank And Broker Commissions BankAndBrokerCommissions	-16000	usd
CY2022	plur	Bank And Broker Commissions BankAndBrokerCommissions	-25000	usd
CY2023	plur	Interest Income On Deposits InterestIncomeOnDeposits	1084000	usd
CY2022	plur	Interest Income On Deposits InterestIncomeOnDeposits	581000	usd
CY2023	us-gaap	Gain Loss On Foreign Currency Fair Value Hedge Derivatives GainLossOnForeignCurrencyFairValueHedgeDerivatives	-157000	usd
CY2022	us-gaap	Gain Loss On Foreign Currency Fair Value Hedge Derivatives GainLossOnForeignCurrencyFairValueHedgeDerivatives	-372000	usd
CY2023	plur	Financial Incomeexpenses Net FinancialIncomeexpensesNet	-798000	usd
CY2022	plur	Financial Incomeexpenses Net FinancialIncomeexpensesNet	1106000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	843000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	887000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1641000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	219000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.21	pure
CY2017Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.80	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2023	plur	Withholding Tax Rate WithholdingTaxRate	0.15	pure
CY2023	plur	Depreciation Tax Rate Percentage DepreciationTaxRatePercentage	0.20	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.20	pure
CY2023	plur	Effective Income Tax Rate Reduced EffectiveIncomeTaxRateReduced	0.06	pure
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	10000000000	ils
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	2900000000000000	ils
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.04	pure
CY2023	us-gaap	Interest Costs Incurred InterestCostsIncurred	75000000000	ils
CY2023	plur	Effective Income Tax Rate Employees Percentage EffectiveIncomeTaxRateEmployeesPercentage	0.20	pure
CY2023	plur	Income Tax Regular Tax Rate IncomeTaxRegularTaxRate	0.23	pure
CY2023	plur	Corporate Tax Rate CorporateTaxRate	0.055	pure
CY2023	plur	Excludes Trade Tax ExcludesTradeTax	0.15	pure
CY2023	us-gaap	Management And Service Fees Base Rate ManagementAndServiceFeesBaseRate	0.035	pure
CY2023	plur	Municipality Of Potsdam MunicipalityOfPotsdam	4.55	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.23	pure
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28887000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	41374000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	80534000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	65384000	usd
CY2023Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4057000	usd
CY2022Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	5583000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	68000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	237000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	286000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	84896000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	71253000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	84896000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71253000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2023	plur	Effective Tax Rate Loss Carryforwards Percentage EffectiveTaxRateLossCarryforwardsPercentage	0	pure
CY2023	plur	Modification Of Warrants To Noncontrolling Interestsnote1c ModificationOfWarrantsToNoncontrollingInterestsnote1c		usd
CY2023	plur	Expiration Of Warrants In Ever After ExpirationOfWarrantsInEverAfter		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross		usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther		usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001158780

Files In Submission

Name	View Source	Status
0001213900-23-076079-index-headers.html	Edgar Link	pending
0001213900-23-076079-index.html	Edgar Link	pending
0001213900-23-076079.txt	Edgar Link	pending
0001213900-23-076079-xbrl.zip	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
f10k2023ex23-1_pluriinc.htm	Edgar Link	pending
f10k2023ex31-1_pluriinc.htm	Edgar Link	pending
f10k2023ex31-2_pluriinc.htm	Edgar Link	pending
f10k2023ex32-1_pluriinc.htm	Edgar Link	pending
f10k2023ex32-2_pluriinc.htm	Edgar Link	pending
f10k2023_pluriinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
plur-20230630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
plur-20230630_lab.xml	Edgar Link	unprocessable
plur-20230630_def.xml	Edgar Link	unprocessable
plur-20230630_pre.xml	Edgar Link	unprocessable
f10k2023_pluriinc_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
plur-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2023 Q3 Form 10-K Financial Statement

#000121390023076079 Filed on September 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2023 Q3 Form 10-K Financial Statement

#000121390023076079 Filed on September 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur